efficacy assessments to inform R&D workflows and regulatory submissions. Its platform integrates diverse computational models for different therapeutic areas, allowing users to run simulations, analyze outcomes, and generate regulatory-relevant digital evidence. InSilicoTrials collaborates with scientific partners and research organizations to expand its library of models and facilitate the adoption of simulation technology in drug development and clinical research. We offer Pharma and MedTech companies state-of-the-art simulation tools that can highly reduce the cost and time of drugs & medical products’ development. The in silico technology can increase the quality of life of millions of patients by allowing cheaper treatments, bringing innovative drugs to the market in a shorter time, together with personalized cures and new solutions for rare diseases.